» Articles » PMID: 39574747

Addressing the Mean-variance Relationship in Spatially Resolved Transcriptomics Data with

Overview
Journal bioRxiv
Date 2024 Nov 22
PMID 39574747
Authors
Affiliations
Soon will be listed here.
Abstract

An important task in the analysis of spatially resolved transcriptomics data is to identify spatially variable genes (SVGs), or genes that vary in a 2D space. Current approaches rank SVGs based on either -values or an effect size, such as the proportion of spatial variance. However, previous work in the analysis of RNA-sequencing identified a technical bias, referred to as the "mean-variance relationship", where highly expressed genes are more likely to have a higher variance. Here, we demonstrate the mean-variance relationship in spatial transcriptomics data. Furthermore, we propose , a statistical framework using Empirical Bayes techniques to remove this bias, leading to more accurate prioritization of SVGs. We demonstrate the performance of in both simulated and real spatial transcriptomics data. A software implementation of our method is available at https://bioconductor.org/packages/spoon.

References
1.
Wang P, Zhang Q, Zhang H, Shao J, Zhang H, Wang Z . Molecular and clinical characterization of ICOS expression in breast cancer through large-scale transcriptome data. PLoS One. 2023; 18(12):e0293469. PMC: 10734928. DOI: 10.1371/journal.pone.0293469. View

2.
Ivanova I, Vermeulen J, Ercan C, Houthuijzen J, Saig F, Vlug E . FER kinase promotes breast cancer metastasis by regulating α6- and β1-integrin-dependent cell adhesion and anoikis resistance. Oncogene. 2013; 32(50):5582-92. PMC: 3898493. DOI: 10.1038/onc.2013.277. View

3.
Jin L, Luo C, Wu X, Li M, Wu S, Feng Y . LncRNA-HAGLR motivates triple negative breast cancer progression by regulation of WNT2 via sponging miR-335-3p. Aging (Albany NY). 2021; 13(15):19306-19316. PMC: 8386551. DOI: 10.18632/aging.203272. View

4.
Huang Z, Yang J, Qiu W, Huang J, Chen Z, Han Y . HAUS5 Is A Potential Prognostic Biomarker With Functional Significance in Breast Cancer. Front Oncol. 2022; 12:829777. PMC: 8913513. DOI: 10.3389/fonc.2022.829777. View

5.
Ekyalongo R, Mukohara T, Funakoshi Y, Tomioka H, Kataoka Y, Shimono Y . TYRO3 as a potential therapeutic target in breast cancer. Anticancer Res. 2014; 34(7):3337-45. View